Chemotherapeutic wafers for High Grade Glioma

Medicine and Dentistry

• Carmustine 100%
• Ganglioglioma 100%
• Surgery 80%
• Randomized Controlled Trial 80%
• Survival 60%
• Recurrent Disease 60%
• Adverse Event 60%
• Quality of Life 60%
• Side Effect 40%
• Hazard Ratio 40%
• Combination Therapy 40%
• Patient 40%
• Survival Time 20%
• Chemotherapeutic Agent 20%
• Drug 20%
• Clinical Examination 20%
• Therapeutic Procedure 20%
• Progression Free Survival 20%
• Central Nervous System 20%
• Assessment 20%
• Chemotherapy Agent 20%
• Chemotherapy 20%
• Biopsy 20%
• Physician 20%
• Glioblastoma 20%
• Life Event 20%
• Neuro-Oncology 20%
• Analysis 20%
• Age 20%
• Arm 20%
• Radiation Therapy 20%
• Diagnosis 20%
• Radiology 20%
• Incidence 20%